Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Lee Weiner, M.D.

Co-Author

This page shows the publications co-authored by Howard Weiner and Francisco Quintana.
Connection Strength

7.939
  1. TrbK controls astrocyte-driven oligodendrocyte copper poisoning. Proc Natl Acad Sci U S A. 2021 08 10; 118(32).
    View in: PubMed
    Score: 0.952
  2. Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology. 2012 Feb 21; 78(8):532-9.
    View in: PubMed
    Score: 0.491
  3. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2010 Nov 30; 107(48):20768-73.
    View in: PubMed
    Score: 0.452
  4. Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish. PLoS One. 2010 Mar 05; 5(3):e9478.
    View in: PubMed
    Score: 0.431
  5. Environmental control of Th17 differentiation. Eur J Immunol. 2009 Mar; 39(3):655-7.
    View in: PubMed
    Score: 0.402
  6. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008 Dec 02; 105(48):18889-94.
    View in: PubMed
    Score: 0.394
  7. Systems biology approaches for the study of multiple sclerosis. J Cell Mol Med. 2008 Aug; 12(4):1087-93.
    View in: PubMed
    Score: 0.381
  8. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008 May 01; 453(7191):65-71.
    View in: PubMed
    Score: 0.377
  9. Understanding natural and pathological autoimmunity. J Neuroimmunol. 2006 May; 174(1-2):1-2.
    View in: PubMed
    Score: 0.327
  10. Serum antibodies to phosphatidylcholine in MS. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4).
    View in: PubMed
    Score: 0.220
  11. Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 Sep; 22(9):1533.
    View in: PubMed
    Score: 0.208
  12. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 05; 22(5):729-740.
    View in: PubMed
    Score: 0.202
  13. Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4(4):e359.
    View in: PubMed
    Score: 0.179
  14. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep. 2016 10 25; 17(5):1318-1329.
    View in: PubMed
    Score: 0.171
  15. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain. J Autoimmun. 2017 01; 76:115-122.
    View in: PubMed
    Score: 0.170
  16. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016 06 28; 7:12015.
    View in: PubMed
    Score: 0.167
  17. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain. 2016 07; 139(Pt 7):1939-57.
    View in: PubMed
    Score: 0.166
  18. Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016 Apr; 3(2):e200.
    View in: PubMed
    Score: 0.162
  19. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis. Neurology. 2014 Dec 09; 83(24):2219-26.
    View in: PubMed
    Score: 0.149
  20. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014 Oct; 20(10):1147-56.
    View in: PubMed
    Score: 0.148
  21. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol. 2013 Jun; 73(6):729-40.
    View in: PubMed
    Score: 0.136
  22. The innate immune system in demyelinating disease. Immunol Rev. 2012 Jul; 248(1):170-87.
    View in: PubMed
    Score: 0.127
  23. Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling. PLoS One. 2012; 7(6):e39576.
    View in: PubMed
    Score: 0.127
  24. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2012 Jul 10; 109(28):11270-5.
    View in: PubMed
    Score: 0.127
  25. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J Neuroimmunol. 2012 Jul 15; 248(1-2):53-7.
    View in: PubMed
    Score: 0.125
  26. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One. 2011; 6(8):e23618.
    View in: PubMed
    Score: 0.119
  27. Oral tolerance. Immunol Rev. 2011 May; 241(1):241-59.
    View in: PubMed
    Score: 0.117
  28. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol. 2010 Sep; 11(9):846-53.
    View in: PubMed
    Score: 0.111
  29. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. J Immunol. 2010 May 01; 184(9):4620-4.
    View in: PubMed
    Score: 0.108
  30. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells. J Clin Immunol. 2010 Jan; 30(1):167-77.
    View in: PubMed
    Score: 0.104
  31. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol. 2009 Sep; 10(9):958-64.
    View in: PubMed
    Score: 0.104
  32. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells. J Immunol. 2008 Nov 01; 181(9):6038-50.
    View in: PubMed
    Score: 0.098
  33. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J Clin Invest. 2008 Apr; 118(4):1532-43.
    View in: PubMed
    Score: 0.094
  34. Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation. Cell Rep. 2020 07 14; 32(2):107892.
    View in: PubMed
    Score: 0.055
  35. MRI phenotypes in MS: Longitudinal changes and miRNA signatures. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e530.
    View in: PubMed
    Score: 0.050
  36. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. Int J Neurosci. 2017 Nov; 127(11):971-980.
    View in: PubMed
    Score: 0.044
  37. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Mult Scler. 2014 Apr; 20(4):438-44.
    View in: PubMed
    Score: 0.034
  38. Gut-tropic T cells that express integrin a4ß7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology. 2011 Dec; 141(6):2109-18.
    View in: PubMed
    Score: 0.030
  39. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010 Sep; 11(9):854-61.
    View in: PubMed
    Score: 0.028
  40. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8706-11.
    View in: PubMed
    Score: 0.027
  41. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 2009 Jun 02; 72(22):1922-30.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.